PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32711407-9	2020	Treatment with RA suppressed the ovarian expression of the NLRP3 inflammasome and regulated the ovarian expression of apoptosis-related proteins.	rosmarinic acid	15-17	NLR family, pyrin domain containing 3	Mus musculus	59-64	
33530569-0	2021	Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome.	rosmarinic acid	29-44	NLR family, pyrin domain containing 3	Mus musculus	104-109	
33530569-6	2021	Moreover, RA-loaded nanovesicles downregulated protein expression of inflammasome components such as NLR family pyrin domain-containing 3 (NLRP3), adaptor protein (ASC) and caspase-1, and the consequent reduction of IL-1beta levels.	rosmarinic acid	10-12	NLR family, pyrin domain containing 3	Mus musculus	101-137	
33530569-6	2021	Moreover, RA-loaded nanovesicles downregulated protein expression of inflammasome components such as NLR family pyrin domain-containing 3 (NLRP3), adaptor protein (ASC) and caspase-1, and the consequent reduction of IL-1beta levels.	rosmarinic acid	10-12	NLR family, pyrin domain containing 3	Mus musculus	139-144	
32711407-10	2020	The results suggested that RA exhibited a protective effect against CP-induced POF potentially by suppressing apoptosis and the NLRP3 inflammasome.	rosmarinic acid	27-29	NLR family, pyrin domain containing 3	Mus musculus	128-133	
35079027-0	2022	NLRP3 inflammasome in rosmarinic acid-afforded attenuation of acute kidney injury in mice.	rosmarinic acid	22-37	NLR family, pyrin domain containing 3	Mus musculus	0-5	
35079027-7	2022	Treatment of RA inhibited the activation of NLRP3 signaling pathway by blocking the activated caspase-1 and downstream signal molecules such as IL-1beta and IL18.	rosmarinic acid	13-15	NLR family, pyrin domain containing 3	Mus musculus	44-49